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The treatment of Osborne-Mendel rats with ethanol in drinking water for 2 weeks resulted in a 3-fold increase of hepatic microsomal hydroxylation
of both p-nitrophenol and aniline, two substrates considered highly selective for P4502E1. No other forms of P450 seemed to be affected. These
results, confirmed by the immunoblot analysis of microsomal protein, showed an induction of P4502E1. The levels of total covalent binding to micro-
somal phospholipid due to 14CHC13 reactive intermediates in ethanol-pretreated microsomes were identical to those measured in microsomes from
untreated rats at any P02. The distribution of radioactivity obtained after transmethylation of the adducts of 14CHCI3 intermediates with microsomal
phospholipids (PL) indicated that binding to fatty acyl chains (due to .CHCI2 radicals) increased with decreasing P02. On the
contrary, the binding to polar heads due to phosgene decreased. The ethanol treatment did not affect binding to either PL moieties. These results
indicated that, in our experimental conditions, the in vitro production of both oxidative and reductive intermediates of CHCI3 in the liver of Osborne-
Mendel rats were not influenced by ethanol consumption.-Environ Health Perspect 102(Suppl 9):25-30 (1994)
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Introduction
The potentiation of CHCl3-induced hepa-
totoxicity in rodents by ethanol (1) and
other aliphatic alcohols (2,3), ketones and
ketogenic compounds (4-8) is well known.
Various mechanisms have been pro-
posed in order to explain this effect, such as
increased absorption in the intestine (9),
depletion ofliver GSH (10,11), inhibition
of hepatocellular regeneration and hepa-
tolobular restoration (3,7), and hepatic
hypermetabolism (12). However, the lead-
ing hypothesis refers to cytochrome P450
induction, responsible for an increase in
CHC13 metabolism (6,13-15). The poten-
tiating effects among alcohols and ketones
differ significantly; this finding has been
related to their qualitatively and quantita-
tively different capacities to induce various
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P450 isoenzymes (16). The involvment of
P4502B1/2 has been evidenced (14) but
much attention was drawn by P4502E1
(15) since it is the main ethanol- and ace-
tone-inducible form (17) able to catalyze
CHC13 biotransformation (13).
Until recently, studies on the associa-
tion of the enhancement of CHC13-
induced hepatotoxicity with its metabolism
were related only to the detection of the
CHC13 oxidation reactive intermediate,
phosgene (6,14). No data are reported on
the role ofthe reductive pathway, through
which CHC13 is biotransformed to radical
species (.CHCI2) (18,19), able to bind
covalently to cellular structures (20,21).
Due to the social relevance of ethanol,
to which most ofhuman population can be
exposed, we decided to study its interaction
with CHC13, although this alcohol is not
the most effective potentiator of CHC13
hepatotoxicity. We investigated the effect
of ethanol pretreatment on the P450-
dependent drug-metabolizing system in
Osborne-Mendel hepatic microsomes.
Then we investigated the effect produced
by the same pretreatment on both oxida-
tion and reduction pathways of CHC13
metabolism, using a CHC13 concentration
(5 mM) at which both metabolic pathways
are expressed (21).
Materials and Methods
Chemicals
(14C)-Chloroform (3.6 mCi/mmole, radio-
chemical purity 99%) was obtained from
New England Nuclear (Boston, MA).
Unlabeled chloroform (IR purity) was from
Merck (Darmstadt, Germany). Liquid
scintillation cocktails Aqualuma and
Lipoluma were purchased from Lumac
Systems A.G. (Basel, Switzerland).
Resorufin was obtained from Fluka (Buchs,
Switzerland). 7-Ethoxycoumarin was from
EGA-Chemie (Steinheim, Germany).
Benzphetamine was supplied by Upjohn
Co. (Kalamazoo, Michigan). Ethoxy-
resorufin and pentoxyresorufin were synte-
tized from resorufin by ethylation with
ethyl iodide and by pentylation with pentyl
iodide, respectively (22).
Enzymes and coenzymes were obtained
from Boehringer GmBh (Mannheim,
Germany). Nitrocellulose filters (0.45 pm),
erythromycin, testosterone (T), 4-
androsten-3,17-dione (17 OT), 16,-
hydroxytestosterone (16P3-OH), and
corticosterone were supplied by Sigma
Chemicals (St. Louis, MO). 2a-,25-, 6a-,
6p-, 7a- and 16ct-hydroxytestosterone
(16a-OH) were obtained from the Steroids
Reference Collection (DN Kirk, Depart-
ment of Chemistry, Queen Mary College,
London, England). Rabbit anti-rat P450
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2E1 polyclonal antibodies were purchased
from Oxygene (Dallas, Texas).
All other analytical grade chemicals were
obtained from common commercial sources.
Animals
Male Osborne-Mendel rats (180-200 g)
were from Zentralinstitut fur Versuchstier-
zucht (Hannover, Germany). They were
maintained on a 12-hr light cycle and pro-
vided food and water adlibitum for 1 week
and then administered 15% (vol/vol)
ethanol in drinking water for 2 weeks.
Liver microsomal preparation were
obtained as previously described (23).
Table 1. Effect of ethanol administration on monooxy-
genase activities in hepatic microsomes from Osborne-
Mendel rats.
Enzymatic Control Ethanol-treated
activity microsomes microsomes
P450a 0.6±0.08 0.54±0.11
b5a 0.14±0.01 0.16±0.03
APNDb 5.3 ± 0.91 4.7 ± 0.6
BZNDb 4.9 ± 0.46 5.7 ± 0.80
ErNDb 0.64 ±0.08 0.50 ± 0.13
AnOHb 0.49 ±0.12 1.10 ± 0.21
pNPHb 0.49 ± 0.006* 1.51 ±0.008*
ECODb 0.55 ± 0.13 0.83 ±0.15
ERODb 0.11 ± 0.03 0.11 ± 0.02
PRODC 7.6 ± 2.5 6.0 ± 1.0
anmole/mg proteins. bnmole/min/mg proteins. Cpmole/
min/mg proteins. Abbreyiations: P450, cytochrome
P450; b5, cytochrome b5; APND, aminopyrine N-
demethylase; BZND, benzphetamine N-demethylase;
ErND, erythromycine N-deethylase; AnOH, aniline
hydroxylase; pNPH, p-nitrophenol hydroxylase; ECOD,
7-ethoxycoumarin-0-deethylase; EROD, ethoxyresorufin
O-deethylase; PROD, pentoxyresorufin-0-depentylase.
*Statistically significant values(p<0.001).
Table 2. Hydroxylation of testosterone by liver micro-
somes of control and ethanol-treated Osborne-Mendel
rats.a
Control Ethanol-treated
Metabolites microsomes microsomes
6a-OH 0.0012 ±0.007 0.018 ± 0.01
7a-OH 0.028 ± 0.01 0.025 ± 0.01
65-OH 0.16±0.04 0.12±0.03
16a-OH 0.31 ± 0.11 0.34± 0.09
16p-OH 0.014 ±0.006 0.010 ±0.004
2a-OH 0.25 ± 0.05 0.22 ± 0.03
2p-OH 0.032 ±0.008 0.024 ± 0.007
17-OT 0.33 ±0.06 0.25 ± 0.05
Total 1.13 ±0.29 1.01 ±0.23
a Results are expressed as nmole/min by mg protein.
Values represent the mean ± standard deviation offour
experiments performed with different microsomal
preparations. Incubations were carried out at 37°C for
15 min with 1 mg/ml microsomal proteins.
BiochemicalAssays
Microsomal protein content was deter-
mined by the method ofOyama and Eagle
(24), using bovine serum albumin as a
standard. Cytochrome P450 and
cytochrome b5 (b5) were measured by the
method of Omura and Sato (25). The
activities for the N-demethylation of
aminopyrine (APND), benzphetamine
(BZND), and erytromycine (ErND) were
assayed by measuring the formation of
formaldehyde (26). Aniline hydroxylase
(AnOH) and p-nitrophenol hydroxylase
(pNPH) were determined according to Ko
et al. (27) and Reinke and Moyer (28).
The 7-ethoxycoumarin- O-deethylase
(ECOD) activity was assayed by the
method ofAitio (29). Ethoxyresorufin-O-
deethylase (EROD) and pentoxyresorufin-
O-depentylase (PROD) activities were
determined by measuring the formation of
the corresponding hydroxy products (30).
Testosterone hydroxylase was assayed
according to an HPLC method as de-
scribed by Platt et al. (31).
Lipids were extracted according to
Folch et al. (32).
GelElectophoresis and
Immunoblotting
SDS-PAGE was carried out using the dis-
continuous system ofLaemmli (33), using
a 1.5-mm thick gel with 3 and 7.5% acry-
lamide in the stacking and separation gel.
Proteins were transferred from the slab gel
to the nitrocellulose filters, following the
method ofTowbin et al. (34). Immuno-
detection ofP4502E1 was performed using
rabbit polyclonal antibodies.
In Vtn Activation of14C-Chloroform
The standard incubation mixture con-
tained microsomal protein (2 mg/ml), G6P
(2 mM), MgCI2 (2 mM) G6P-dehydroge-
nase (1 U/ml), EDTA (1 mM), NADP
(0.2 mM) and 14C-chloroform 5 mM in
50 mM Tris-HCl buffer, pH7.4. When
anoxic conditions were required, the incu-
bation mixture also contained an oxygen
scavenging enzyme system. Mixture to be
incubated under hypoxic (about 1% P02)
or anoxic conditions were flushed with
ultrapure N2 for 20 min; a mixture of 02
N2 (5:95) was flushed for 20 min when
incubations were to be carried out at 5%
P02- A detailed description of the proce-
dure wasreportedpreviously (20).
CovalentBinding of14C-Chloroform
Metabolites
Covalent binding of 14C-label to microso-
mal lipid was measured after 20 min incu-
bation according to the method ofUehleke
(35), with minor modifications (20). The
regioselective binding of 14C-chloroform
metabolites to microsomal phospholipids
(PL)-polar heads and/or fatty acyl chains
was determined after the acid catalyzed
transmethylation of PL-adducts, as
described in detail by De Biasi et al. (36).
Briefly, the lipid extract was dissolved
in 1 ml of anhidrous methanol: benzene:
H2SO4 (75:25:1), and vigorously shaken
for 1 hr at 70°C. The reaction mixture was
cooled in an ice bath, then 2 ml petroleum
ether (bp 40°-70°) and 1 ml 0.26M
K2HPO4 were added. After 10 min vigor-
ous shaking, the mixture was centrifuged
(3000 rpm, 10 min). The lower aqueous
AB
Figure 1. Immunoblot analysis of hepatic micro-
somes from control (lane A) and ethanol-treated rats
(lane B). Microsomes (12 pg protein loaded in each
lane) were subjected to SDS-PAGE electrophoresis
followed by immunoblotting.
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layer, containing the hydrophylic polar
heads, was transferred into a plastic vial
containing 17 ml Aqualuma. The upper
organic phase, containing the PL fatty acid
methyl esters, was washed twice and then a
2-ml aliquot was transferred into a plastic
vial containing 10 ml Lipoluma.
Calculations
Data obtained with control and ethanol
treated microsomes were compared by
means ofthe Student's t-test.
Results
Effect ofEthanol onHepati Drug
MetabolizingEnzymes
The effect of ethanol administration on
hepatic cytochrome P450 and b5 content
and some monooxygenase activities is
shown in Table 1. With respect to micro-
somes from control animals, the ethanol
treatment resulted in a 2.4- and a 3-fold
increase of the oxidation rates ofp-nitro-
phenol and aniline, two substrates consid-
ered to be highly selective for P4502E1. All
the other monooxygenase activities, as well
as the amount of both P450 and
cytochrome b5, did not exhibit any signifi-
cant difference between control and
ethanol-treated rat liver microsomes.
To investigate more specifically the
effect of ethanol administration to
Osborne-Mendel rats on the constitutive
P450 isozymes, the metabolism of an
endogenous substrate, such as T was stud-
ied. Results presented in Table 2 show that
no significant differences were present
between control and ethanol-treated
hepatic microsomes either in the total level
ofT-hydroxylation or in the production of
any specific T-metabolite, including 16p-
OH and 17 OT, which are associated,
respectively, with P450 2B1/2 (the major
PB-inducible P450 isoenzyme) and P450
2C11 (the most relevant constitutive P450
form in the rat liver).
The immunoblot analysis of microso-
mal protein Figure 1 using rabbit anti-rat
P4502E1 polyclonal IgG, evidenced the
absence ofany reaction in control micro-
somes for lane A, whereas a band is present
in lane B where ethanol-treatred rat liver
microsomes were loaded.
EffectofEthanol onChloroform
Metabolism
The levels of total covalent binding to
microsomal phospholipids due to 14CHCI3
reactive intermediates in ethanol-pretreated
Osborne-Mendel rat liver microsomes
were almost indentical to those measured
in microsomes from untreated rats at any
tested P02 (Figure 2).
With the transmethylation of the PL-
adducts of Osborne-Mendel rat liver
microsomes, it is possible to selectively
quantitate the production ofoxidation and
reduction intermediates ofCHC13 metabo-
lism, which exhibit a typical regioselectivity
in their attack to PL. Indeed, while 'CHCl2
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radicals, reductively produced from
14CHCl3, preferentially bind to PL fatty
acyl chains (FC), the major product of
CHC13 oxidation, phosgene, has in PL
polar heads (PH) its main target (36). In
Figure 3, radioactivity associated to PH,
expression of CHC13 oxidation, measured
in control and in ethanol-treatred Osborne-
Mendel rat liver microsomes is shown. It
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Figure 2. Oxygen concentration dependence of in vitrocovalent binding of CHCI3 metabolites to liver microsomal
phospholipids. Incubations were carried out at 5 mM"CHC13 with control (filled bars) and ethanol-treated (dotted
bars) Osborne-Mendel rats hepatic microsomes. Values represent means and standard deviations calculated from
three different microsomal preparations.
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Figure 3. Effect of ethanol-pretreatment on in vitro covalent binding of CHCI3 metabolites to liver microsomal Pl
polar heads. Incubations were carried out at 5 mM "CHCI3, at different 02 tensions both with control (filled bars)
and ethanol treated (dotted bars) Osborne-Mendel rat hepatic microsomes. Values represent means and standard
deviations calculated from three different microsomal preparations. For the statistically significant difference
between control and treated microsomes, the level ofpis reported.
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Figure 4. Effect of ethanol-pretreatment on in vitro covalent binding of CHCI3 metabolites to liver microsomal PL
fatty acyl chains (for details see Figure 3).
appears that binding to PH increased on
increasing pO2, but no differences were
present between control and treated micro-
somes; only values measured at 1% pO2
exhibited some degree ofstatistical signifi-
cance. The binding to FC, considered as an
index of CHC13 reduction in control and
treated microsomes is shown in Figure 4.
The opposite dependence on pO2 with
respect to PH was evidenced: the levels of
radioactivity associated to FC decreased on
increasing pO2. Moreover, levels measured
both in control and in treated microsomes
were almost identical. The slight statistical
significance of the difference between values
at 5% pO2 was not considered relevant. As
a consequence, the relative contribution of
the two different CHC13 metabolites to the
almost similar levels of PL total covalent
binding measured in different oxygenation
conditions (Figure 2), markedly varied with
P02 (Figures 3 and 4). Indeed, the ratios of
radioactivity associated to PH versus
radioactivity to FC (PH/FC ratios) were
0.28, 0.21, 1.34, and 38.5 in control
microsomes. The ratios were 0.31, 0.36,
2.77 and 4.65 in ethanol treated micro-
somes, at increasing P02 from 0 to 1, 5 and
20%, respectively.
Discussion
Similar to previous findings with rabbits,
(37,38) hamsters (39), and different strains
ofmice and rats (40,41), the present results
clearly indicate that the oral administration
of ethanol to Osborne-Mendel rats,
resulted in the induction of P4502E1. In
fact, the significant increase ofthe hepatic
P4502E1-linked monooxygenase activities
was confirmed by the immunodetection in
microsomes from ethanol-treated rat liver,
of a band corresponding to P4502E1. That
band was absent in hepatic microsomes
from control Osborne-Mendel rats.
No other forms of P450 seemed to be
significantly affected by ethanol pretreat-
ment, as demonstrated by the unchanged
metabolism of either exogenous and
endogenous P450 substrates.
Previous works evidenced that both
P4502B1/2 and P4502E1 are involved in
CHC13 metabolism, which can therefore be
affected by pretreatment with PB, alcohols
and ketones (6,13-15,42).
Although our pretreatment procedure
resulted in the induction of P4502E1, in
hepatic microsomes from Osborne-Mendel
rats, no substantial quantitative changes
were detectable in chloroform metabolism,
.which is expressed as 14CHCl3-derived
reactive intermediates covalently bound to
microsomal PL (Figure 2).
Moreover, considering the typical
regioselectivity in the attack to PL exhib-
ited by oxidation and reduction intermedi-
ates of CHCl3 (36), it appeared that
ethanol was also uneffective in qualitatively
modifying the pattern ofCHCl3 metabo-
lism (Figures 3 and 4). Indeed, the two
pathways are similarly expressed in control
and ethanol-treated microsomes.
The relative contributions of P450
2B1/2 and P450 2E1 appear to be depen-
dent on the substrate concentration.
Indeed, it has been suggested (42) that at
low chloroform concentrations (about 0.1
mM) its metabolism i catalyzed mainly by
P450 2E1 (13,15,42), while P450 2B1/2
may be significantly responsible for CHC13
activation at a higher haloform concentra-
tion of 5 mM (14). Data on the effects of
ethanol on chloroform metabolism at high
substrate concentration were only based on
the detection of chloroform oxidation
products (14). Our data indicate that both
the oxidative and the reductive metabolism
ofCHCl3 are not affected by P450 2E1 at
5 mM CHC13, a concentration at which
the two pathways are expressed (21).
One ofthe most relevant features ofthe
CHC13 metabolism is that the oxygenation
of the incubation mixture was of major
importance in determining the oxidative
and/or reductive nature of CHCl3 activa-
tion (21). In this paper, we show that at 1
and 5% P02, representing the physiologi-
cal range of02 tensions typical ofthe liver
(43), the two pathways are concurrently
present. It appeared also that in our in vitro
conditions the shift from oxidation to
reduction occurred just in this range Of
P02. Indeed the relative magnitude ofthe
binding to PH and FC was reversed mostly
between 5 and 1% P02 (Figures 3 and 4).
Rats treated with ethanol showed a
higher rate of 02 consumption in the liver
than control rats (44). This phenomenon
may increase the state of physiological
hypoxia of the liver and suggests that the
consequent alteration of the delicate bal-
ance between the oxidative and the reduc-
tive activation ofCHCl3 may concur in the
potentiation ofCHCl3 toxicity.
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